MedTrace Logo

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

NCT06921408 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2026-05-15

No results posted yet for this study

Summary

This study aims to determine the positive predictive value of incidental cardiac uptake on bone scintigraphy for diagnosing transthyretin cardiac amyloidosis, in patients who underwent scintigraphy for reasons other than suspected amyloidosis. The study is an observational, descriptive, multicenter, national study using retrospective data from routine care. Patients with incidental cardiac uptake will be recalled for further diagnostic assessment.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University Hospital, Lille

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-07-01
Completion
2027-12-01

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06921408 on ClinicalTrials.gov